Metropolitan Life Insurance Company (MetLife)’s Stemline Therapeutics, Inc. STML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
2020
Q1
$66.4K Buy
2019
Q4
$127K Sell
2019
Q3
$139K Hold
2019
Q2
$205K Hold
2019
Q1
$172K Buy
2018
Q4
$81K Hold
2018
Q3
$141K Hold
2018
Q2
$137K Buy
2018
Q1
$124K Hold
2017
Q4
$126K Sell
2017
Q3
$175K Buy
2015
Q2
Sell
2015
Q1
$185K Buy
2014
Q2
Sell
2014
Q1
$162K Hold
2013
Q4
$156K Hold
2013
Q3
$361K Hold
2013
Q2
$190K Buy